USSTOCK.TODAY
Regular Market
Log in Sign up

Medtronic reports positive real-world clinical results for cardiac ablation technology

Medical Device Network · ·by G4L

MDT Medtronic Plc
$102.79 +0.97%
View chart & analysis →
  1. 1Medtronic reported positive real-world clinical registry results for its cardiac ablation technology.
  2. 2The PulseSelect PFA system recorded a 100% success rate in the REAL PULSE prospective study.
  3. 3Vice President Kaldu Taraki said the favorable results reinforce confidence in the technology's safety and performance.

So what's the key point?

Medtronic's cardiac ablation technology recorded a 100% success rate in a real-world study. These results add confidence in the safety and performance of the technology.

Source Medical Device Network · View original ↗

Related 3-line summaries

Medtronic to spin off diabetes unit and secure approximately 55 million shares of its own stock The Motley Fool +1 · Nov 1Medtronic Receives European CE Mark for Next-Generation Pacemaker Portfolio Medical Device Network · Oct 21Stryker enters strategic partnership with CMR Surgical and invests approximately $400 million InvestorsHub +3 · Oct 12
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news